Literature DB >> 20555409

Effect of sex steroid hormones on brain edema, intracranial pressure, and neurologic outcomes after traumatic brain injury.

Nader Shahrokhi1, Mohammad Khaksari, Zahra Soltani, Mehdi Mahmoodi, Nouzar Nakhaee.   

Abstract

Recent studies have reported that estrogen and progesterone have a neuroprotective effect after traumatic brain injury (TBI); however, the mechanism(s) for this effect have not yet been elucidated. The aim of the present study was to investigate the role of sex steroid hormones on changes in brain edema, intracranial pressure (ICP), and cerebral perfusion pressure (CPP) after TBI in ovariectomized (OVX) rats. In this study, 50 female rats were divided into 5 groups: control (intact), sham, and 3 TBI groups consisting of vehicle, estrogen (1 mg/kg), and progesterone (8 mg/kg). TBI was induced by the Marmarou method, and the hormones were injected i.p. 30 min after TBI. ICP was measured in the spinal cord, and CPP was calculated by subtracting the mean arterial pressure (MAP) from ICP. The results revealed that brain water content after TBI was lower (p < 0.001) in the estrogen and progesterone groups than in the vehicle group. After trauma, ICP was significantly higher in TBI rats (p < 0.001). The ICP in the estrogen and progesterone groups decreased at 4 and 24 h after TBI compared with vehicle (p < 0.001 and p < 0.05, respectively). The CPP in the estrogen and progesterone groups increased after 24 h compared with vehicle (p < 0.001). Also after TBI, the neurological score (veterinary coma scale) was significantly higher than vehicle at 1 h (p < 0.01) and 24 h (p < 0.001) in the group treated with estrogen. In conclusion, pharmacological doses of estrogen and progesterone improved ICP, CPP, and neurological scores after TBI in OVX rats, which implies that these hormones play a neuroprotective role in TBI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20555409     DOI: 10.1139/y09-126

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  43 in total

Review 1.  Investigational agents for treatment of traumatic brain injury.

Authors:  Ye Xiong; Yanlu Zhang; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Investig Drugs       Date:  2015-03-01       Impact factor: 6.206

2.  17β-estradiol confers protection after traumatic brain injury in the rat and involves activation of G protein-coupled estrogen receptor 1.

Authors:  Nicole L Day; Candace L Floyd; Tracy L D'Alessandro; William J Hubbard; Irshad H Chaudry
Journal:  J Neurotrauma       Date:  2013-07-23       Impact factor: 5.269

3.  Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences.

Authors:  Kristin L Russell; Katrina M Kutchko; Stephen C Fowler; Nancy E J Berman; Beth Levant
Journal:  J Neurosci Methods       Date:  2011-05-11       Impact factor: 2.390

Review 4.  Progesterone for neuroprotection in pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Emin Fidan; Rachel M Stanley; Corina Noje; Hülya Bayir
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

5.  Estrone is neuroprotective in rats after traumatic brain injury.

Authors:  Joshua W Gatson; Ming-Mei Liu; Kareem Abdelfattah; Jane G Wigginton; Scott Smith; Steven Wolf; James W Simpkins; Joseph P Minei
Journal:  J Neurotrauma       Date:  2012-05-08       Impact factor: 5.269

6.  Effects of progesterone on the neonatal brain following hypoxia-ischemia.

Authors:  Rafael Bandeira Fabres; Luciana Abreu da Rosa; Samir Khal de Souza; Ana Lucia Cecconello; Amanda Stapenhorst Azambuja; Eduardo Farias Sanches; Maria Flavia Marques Ribeiro; Luciano Stürmer de Fraga
Journal:  Metab Brain Dis       Date:  2018-01-23       Impact factor: 3.584

7.  Management of increased intracranial pressure.

Authors:  Danielle K Sandsmark; Kevin N Sheth
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

Review 8.  Sex-related responses after traumatic brain injury: Considerations for preclinical modeling.

Authors:  Claudia B Späni; David J Braun; Linda J Van Eldik
Journal:  Front Neuroendocrinol       Date:  2018-05-18       Impact factor: 8.606

Review 9.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

10.  Effect of progesterone intervention on the dynamic changes of AQP-4 in hypoxic-ischaemic brain damage.

Authors:  Xiaojuan Li; Ruiying Bai; Junhe Zhang; Xiaoyin Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.